Preclinical studies have demonstrated that PT-141 significantly enhances sexual behavior in female rodents. Palatin Technologies, Inc. (AMEX: PTN) is developing PT-141 as an investigational treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results